Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | +2.06% | -7.24% | -17.29% |
Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
Chart calendar Novavax, Inc.
Upcoming events on Novavax, Inc.
Past events on Novavax, Inc.
2024-04-03 02:40 pm | World Vaccine Congress |
2024-04-03 10:25 am | World Vaccine Congress |
2024-04-03 10:10 am | World Vaccine Congress |
2024-03-06 01:30 pm | TD Cowen Health Care Conference |
2024-02-28 08:30 am | Q4 2023 Earnings Call |
2024-02-28 08:00 am | Q4 2023 Earnings Release |
2024-01-08 08:15 pm | JPMorgan Healthcare Conference |
2023-11-15 04:00 am | Jefferies London Healthcare Conference |
2023-11-09 08:32 am | Q3 2023 Earnings Release |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-10-19 04:30 am | World Vaccine Congress - Perretti, A |
2023-10-18 08:00 am | World Vaccine Congress - Shinde, V |
2023-10-17 07:45 am | World Vaccine Congress - Zatonski, M |
2023-10-14 12:15 pm | IDWeek Conference - Poster No. - 2337 |
2023-10-13 12:15 pm | IDWeek Conference - Poster No. - 1371 |
2023-09-12 10:15 am | Baird Global Healthcare Conference |
2023-09-11 04:30 pm | H.C. Wainwright Global Investment Conference |
2023-08-08 08:30 am | Q2 2023 Earnings Call |
2023-08-08 08:00 am | Q2 2023 Earnings Release |
2023-07-11 08:30 am | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 18,7 11,8 57.99% | 476 398 19.36% | 1 146 1 263 -9.25% | 1 982 1 947 1.77% | 984 1 014 -3.03% | 850 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -616 -455 -35.42% | -525 -487 -7.88% | -111 |
EBIT Million USD | Released Forecast Spread | -130 -121 -7.5% | -417 -393 -6.04% | -1 687 -979 -72.21% | -645 -480 -34.41% | -567 -424 -33.66% | -62,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -133 -128 -3.94% | -418 -383 -9.33% | -1 715 -1 007 -70.2% | -654 -548 -19.24% | -543 -394 -37.66% | -101 |
Net income Million USD | Released Forecast Spread | -133 -130 -2.38% | -418 -383 -9.33% | -1 744 -1 021 -70.82% | -658 -548 -20.13% | -545 -413 -31.9% | -90,5 |
EPS USD | Released Forecast Spread | -5,51 -5,42 -1.59% | -7,27 -6,58 -10.53% | -23,4 -13,7 -71.07% | -8,42 -6,98 -20.66% | -5,41 -4,22 -28.15% | -0,73 |
Announcement Date | 11/03/20 | 01/03/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 222 332 -33.03% | 704 845 -16.71% | 186 1 017 -81.72% | 735 555 32.24% | 357 383 -6.72% | 81,0 94,5 -14.35% | 424 259 63.88% | 187 96,5 93.76% | 291 322 -9.51% | 101 | 76,7 | 77,4 | 617 |
EBITDA Million USD | Released Forecast Spread | -119 310 -138.36% | -173 -120 -43.73% | -149 | -121 | -109 | 186 | |||||||
EBIT Million USD | Released Forecast Spread | -825 -114 -626.51% | 209 247 -15.35% | -483 486 -199.33% | -127 139 -191.53% | -244 -90,2 -170.23% | -313 -278 -12.54% | 55,5 -121 145.98% | -126 -223 43.74% | -184 -40,9 -348.58% | -134 | -96,3 | -108 | 272 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -830 -118 -604.95% | 206 242 -14.95% | -509 495 -202.89% | -166 93,2 -278.36% | -185 -87,8 -110.23% | -293 -299 2.07% | 57,9 -94,1 161.53% | -131 -214 38.43% | -177 -26,9 -555.91% | -139 | -104 | -109 | 250 |
Net income Million USD | Released Forecast Spread | -846 -124 -584.19% | 203 213 -4.69% | -510 449 -213.66% | -169 132 -227.32% | -182 -74,2 -145.57% | -294 -291 -1.16% | 58,0 -101 157.16% | -131 -217 39.77% | -178 -46,5 -283.41% | -136 | -102 | -107 | 244 |
EPS USD | Released Forecast Spread | -11,2 -1,80 -520.36% | 2,56 2,65 -3.54% | -6,53 5,50 -218.68% | -2,15 1,64 -231.02% | -2,28 -1,01 -126.76% | -3,41 -3,42 0.29% | 0,58 -1,16 149.81% | -1,26 -2,29 45.05% | -1,44 -0,45 -221.19% | -1,06 | -0,77 | -0,74 | 1,68 |
Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 09/11/23 | 28/02/24 | - | - | - | - |
Past sector events for Novavax, Inc.
2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVAX Stock
- Calendar Novavax, Inc.